Vassiliki Economides's Insider Trades & SAST Disclosures
Vassiliki Economides's most recent trade in Gritstone Bio Inc was a trade of 250,437 Common Stock done . Disclosure was reported to the exchange on April 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Vassiliki Economides.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 250,437 | 0 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 215,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 215,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Other type of transaction at price $ 0.00 per share. | 04 Apr 2025 | 138,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Economides Vassiliki | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.02 per share. | 18 Dec 2024 | 12,000 | 250,437 (0%) | 0% | 0.0 | 180 | Common Stock |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 27,128 | 276,186 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 0.75 per share. | 15 May 2024 | 13,749 | 262,437 (0%) | 0% | 0.7 | 10,288 | Common Stock |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Vassiliki Economides | EVP, CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 35,000 | 227,762 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Vassiliki Economides | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.90 per share. | 23 May 2023 | 12,000 | 214,058 (0%) | 0% | 1.9 | 22,829 | Common Stock |
| Gritstone Bio Inc | Vassiliki Economides | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2023 | 179,058 | 202,058 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 138,000 | 138,000 | - | - | Stock Option (Right to Buy) | |
| Gritstone Bio Inc | Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2022 | 23,000 | 23,000 (0%) | 0% | 0 | Common Stock | |
| Gritstone Bio Inc | Vassiliki Economides | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Kezar Life Sciences Inc | Vassiliki Economides | SVP, Strategy & External Aff. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 110,000 | 110,000 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges